FDA Inspection 960124 — Viroclinics Biosciences B.V.
The FDA completed an inspection of Viroclinics Biosciences B.V. on February 3, 2016 in Rotterdam. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 3, 2016
- Fiscal Year
- 2016
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Rotterdam (Netherlands)